Alvimopan, a Peripherally Acting μ-Opioid Receptor Antagonist, is Associated with Reduced Costs after Radical Cystectomy: Economic Analysis of a Phase 4 Randomized, Controlled Trial - Concepedia

Concepedia

Publication | Closed Access

Alvimopan, a Peripherally Acting μ-Opioid Receptor Antagonist, is Associated with Reduced Costs after Radical Cystectomy: Economic Analysis of a Phase 4 Randomized, Controlled Trial

67

Citations

22

References

2013

Year

Teresa L. Kauf, Robert S. Svatek, Gilad E. Amiel, Timothy L. Beard, Sam S. Chang, Amr Fergany, R. Jeffrey Karnes, Michael O. Koch, Jerome F. O’Hara, Cheryl T. Lee,

The Journal of Urology

Abstract

In patients treated with radical cystectomy alvimopan decreased hospitalization cost by reducing the health care services associated with postoperative ileus and decreasing the hospital stay.

References

	Year	Citations

Page 1